The 37-amino acid calcitonin gene-related peptide (CGRP) is a potent endogenous vasodilatorthought to be implicated in the genesis of migraine attack. CGRP antagonists may thus have therapeuticvalue for the treatment of migraine. The CGRP C-terminally derived peptide [D
31,P
34,F
35]CGRP(27-37)-NH
2 was recently identified as a high-affinity hCGRP
1 receptor selective antagonist. Reasonable CGRP
1affinity has also been demonstrated for several related analogues, including [D
31,A
34,F
35]CGRP(27-37)-NH
2. In the study presented here, conformational and structural features in CGRP(27-37)-NH
2 analoguesthat are important for hCGRP
1 receptor binding were explored. Structure-activity studies carried out on[D
31,P
34,F
35]CGRP(27-37)-NH
2 resulted in [D
31,P
34,F
35]CGRP(30-37)-NH
2, the shortest reported CGRPC-terminal peptide analogue exhibiting reasonable hCGRP
1 receptor affinity (
Ki = 29.6 nM). Furtherremoval of T
30 from the peptide's N-terminus greatly reduced receptor affinity from the nanomolar tomicromolar range. Additional residues deemed critical for hCGRP
1 receptor binding were identified froman alanine scan of [A
34,F
35]CGRP(28-37)-NH
2 and included V
32 and F
37. Replacement of the C-terminalamide in this same peptide with a carboxyl, furthermore, resulted in a greater than 50-fold reduction inhCGRP
1 affinity, thus suggesting a direct role for the amide moiety in receptor binding. The conformationalproperties of two classes of CGRP(27-37)-NH
2 peptides, [D
31,X
34,F
35]CGRP(27-37)-NH
2 (X is A orP), were examined by NMR spectroscopy and molecular modeling. A
![](/images/gifchars/beta2.gif)
-turn centered on P
29 was a notablefeature consistently observed among active peptides in both series. This turn led to exposure of the criticalT
30 residue to the surrounding environment. Peptides in the A
34 series were additionally characterized bya stable C-terminal helical turn that resulted in the three important residues (T
30, V
32, and F
37) adoptingconsistent interspatial positions with respect to one another. Peptides in the P
34 series were comparativelymore flexible at the C-terminus, although a large proportion of the [D
31,P
34,F
35]CGRP(27-37)-NH
2calculated conformers contained a
![](/images/gifchars/gamma.gif)
-turn centered on P
34. These results collectively suggest that turnstructures at both the C-terminus and N-terminus of CGRP(27-37)-NH
2 analogues may help toappropriately orient critical residues (T
30, V
32, and F
37) for hCGRP
1 receptor binding.